Preventative therapy in primary biliary cirrhosis

Clinics in Liver Disease

Volumn 7, Issue 4, 2003, Pages 911-921

  Floreani, Annarosa ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; ESTRADIOL; ESTROGEN; GLUCONATE CALCIUM; LIVER ENZYME;

AUTOIMMUNE DISEASE; DISEASE COURSE; EVIDENCE BASED MEDICINE; GENE THERAPY; GENETIC PREDISPOSITION; HORMONE SUBSTITUTION; HUMAN; INFECTION; LIVER TRANSPLANTATION; OSTEOPENIA; OSTEOPOROSIS; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; REVIEW; RISK FACTOR;

EID: 0141994823     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(03)00094-1     Document Type: Review

References (52)

1. Rubel LR, Seef LB, Patel V. Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome. Arch Pathol Lab Med 1984;108:360-1.
2. Burak KW, Urbanski SJ, Swain MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis. A new overlap of autoimmune liver diseases. Dig Dis Sci 2001;46:2043-7.
3. Long RG, Scheuer PJ, Sherlock S. Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology 1977;72:1204-7.
4. Beswick DR, Klatskin G, Boyer JL. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology 1985;89:267-71.
5. Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand J Gastroenterol 1989;24:57-64.
6. Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology 1990;98:1567-71.
7. Mitchison HC, Lucey MR, Kelly PJ, Neuberger JM, Williams R, James OF. Symptoms, development and prognosis in primary biliary cirrhosis: a study in two centres. Gastroenterology 1990;99:778-84.
8. Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20:707-13.
9. Uddenfeldt P, Danielsson A. Primary biliary cirrhosis: survival of a cohort followed for 10 years. J Int Med 2000;248:292-8.
10. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1-7.
11. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology 1985;89:1084-91.
12. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1-7.
13. Christensen E, Altman DG, Neuberger J, De Stavola B, Tygstrup N, Williams R, et al. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Hepatology 1993;105:1865-76.
14. Hughes MD, Raskino CL, Pocock SJ, Biagini MR, Burroughs AK. Prediction of short-term survival with an application in primary biliary cirrhosis. Stat Med 1992;11:1731-45.
15. Wolfhagen FHJ, van Buuren HR, Vleggaar FP, Schalm SW. Management of osteoporosis in primary biliary cirrhosis. Baill Clin Gastroenterol 2000;14:629-41.
16. Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OFW. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 1997;26:1138-42.
17. Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Naccarato R. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. Hepatology 1999;29:1425-8.
18. Mitchison HC, Bassendine MF, Hendrick A, Bennett MK, Bird G, Watson AJ, et al. Positive antimitochondrial antibody, but normal alkaline phosphatase. Is this primary biliary cirrhosis? Hepatology 1986;6:1279-84.
19. Balli F, Di Biase AR, Viola L. Autoimmune hepatitis: paediatric aspects. Pediatr Med Chir 1996;18:123-9.
20. Corpechot C, Carrat F, Poupon R, Poupon R-E. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology 2002;122:652-8.
21. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-90.
22. Balan V, Batts K, Porayko M, Krom R, Ludwig J, Wiesner R. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology 1993;18:1392-8.
23. Dietze D, Vogel W, Margreiter R. Primary biliary cirrhosis (PBC) after liver transplantation. Transpl Proc 1990;22:1501-2.
24. Polson R, Portmann B, Neuberger J, Caine R, Williams R. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Gastroenterology 1989;97:715-25.
25. Sebagh M, Farges O, Dubel L, Samuel D, Bismuth H, Reynes M. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation. Transplantation 1998;65:1328-33.
26. Abu-Elmagd K, Demetris J, Rakela J, et al. Transplantation for primary biliary cirrhosis. Hepatology 1997;26:176A [abs].
27. Liebermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 2001;33:22-7.
28. Ferrell L, Lee R, Brixko C, Bass NM, Lake JR, Roberts JP, et al. Hepatic granulomas following liver transplantation. Transplantation 1995;60:926-33.
29. Gouw A, Haagsma E, Manns M, Klompmaker I, Slooff M, Gerber M. Is there recurrence of primary biliary cirrhosis after liver transplantation? J Hepatol 1994;20:500-7.
30. Dmitrewski J, Hubscher S, Mayer A, Neuberger J. Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. J Hepatol 1996;24:253-7.
31. Neuberger J. Primary biliary cirrhosis. In: Lindor KD, Heathcote EJ, Poupon R, editors. Transplantation and recurrent disease. In Primary biliary cirrhosis: from pathogenesis to clinical treatment. Dordrecht, The Netherlands: Kluwer Academic Publishers PV; 1998. p. 155-62.
32. Hubscher SG, Elias E, Buckels JAC, Mayer D, McMaster P, Neuberger JM. Primary biliary cirrhosis: histological evidence of recurrence after liver transplantation. J Hepatol 1993;18:173-84.
33. Hashimoto E, Shimada M, Noguchi S, Tanai M, Tokushige K, Hayashi N, et al. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up. Liver Transpl 2001;7:596-9.
34. Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evroski J, et al. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000;118:145-51.
35. Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2000;35:126-31.
36. Pares A, Guanabens N, Alvarez L, De Osaba MJ, Oriola J, Pons F, et al. Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 2001;33:554-60.
37. Lakatos LP, Bajnok E, Hegedus D, Toth T, Lakatos P, Szalay F. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2002;14:733-40.
38. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995;95:2581-6.
39. Collier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002;50(Suppl 1)51-9.
40. Floreani A. Osteoporosis is not a specific complication of primary biliary cirrhosis (PBC) [letter]. Gut 2002;50:898.
41. Sambrook PN, Eisman JA. Osteoporosis prevention and treatment. Med J Aust 2000;172:226-9.
42. Crippin JS, Jorgenesen RA, Dickson ER, Lindor KD. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 1994;89:47-50.
43. Olsson R, Mattsson LA, Obrant K, Mellstrom D. Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 1999;19:188-92.
44. Fentiman IS. Oral contraceptives, hormone replacement therapy and breast cancer. Int J Clin Pract 2002;56:755-9.
45. Navasa M, Pares A, Bruguera M, Caballeria J, Bosch J, Rodes J. Portal hypertension in primary bihary cirrhosis. Relationship with histological features. J Hepatol 1987;5:292-8.
46. Colina F, Pinedo F, Solis JA, Moreno D, Nevado M. Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis. Gastroenterology 1992;102:1319-24.
47. Bressler B, El-Ashry D, Heathcote J. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for esophageal varices detection? [abstract]. Hepatology 2002;36:418A.
48. Committee for portal hypertension of the Italian Association for the Study of the Liver. AISF practice guidelines for portal hypertension. Ital J Gastroenterol Hepatol 1999;31:224-34.
49. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2000;46(Suppl III):iii1-15.
50. Kingham JGC, Parker DR. The association between primary biliary cirrhosis and celiac disease: a study of relative prevalences. Gut 1998;42:120-2.
51. Sorensen HT, Thulstrup AM, Blomqvist P, Norgaard B, Fonager K, Ekbom A. Risk of primary biliary cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 1999;44:736-8.
52. Floreani A, Betterle C, Baragiotta A, Martini S, Venturi C, Basso D, et al. Prevalence of celiac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult celiac disease patients in Italy. Dig Liver Dis 2001;33:258-61.